CD274 and cancer: RNAish detection of PD-L1 mRNA might therefore be more sensitive when compared to PD-L1 protein expression by IHC and might serve as a better predictive biomarker for immune checkpoint therapy, specifically as in various cancer types PD-L1 negative patients did show response to PD-L1/PD-1 checkpoint inhibition (49).